||Recombinant Human AKR1C4 (Accession # NP_001809) Met1-Tyr323 was produced in E. coli-derived.
|Predicted N Terminal:
||Supplied as a 0.2 µm filtered solution in Tris, NaCl, Glycerol and DTT.
||Measured by its NADP+-dependent oxidation of cholic acid.The specific activity is >300 pmol/min/µg, as measured under the described conditions.
||Recombinant Human AKR1C4 has a calculated MW of 37 kDa. In SDS-PAGE migrates as 36-38 kDa, reducing conditions.
||>90%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 µg per lane.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).